Riyadh — Mubasher: Twareat Medical Care Company (TMC) reported a net profit of SAR 13.23 million during the first half (H1) of 2026, reflecting a 139.37% increase from the SAR 5.53 million in H1-25, according to a bourse filing.
Earnings per share (EPS) rose to SAR 0.33 in H1-26, compared to SAR 0.14 in the previous year.
The revenue increased by 65.08% to SAR 149.76 million in H1-26 from SAR 90.72 million in H1-25.
Twareat attributed the annual revenue growth to the execution of a new project for the National Unified Procurement Company (NUPCO) and the commencement of new medical service contracts in the Eastern Province.
Profitability was further supported by a decrease in general and administrative expenses following the absence of professional fees incurred in the prior year.
These gains were partially offset by higher expected credit losses and increased financing costs during the current period.
Total shareholders' equity, excluding non-controlling interests, stood at SAR 59.87 million at the end of H1-26, a decrease of 4.61% from SAR 62.76 million in H1-25.
Meanwhile, Twareat’s weighted average number of shares remained constant at 40 million.
